American Health & Medical Research Association
Evidence review

Hot flashes can last a decade, and scientists traced them to a thermostat in the brain

In a major U.S. study, frequent hot flashes lasted a median of 7.4 years. Below, we look at what sets them off in the brain, what they may signal about the heart and how treatments compare.

Sources15, listed below Reading time15 minutes

Where the evidence stands

  • Strong evidence Hormone therapyFezolinetantSSRIs and SNRIs, including low-dose paroxetineGabapentinOxybutyninCBT or clinical hypnosis
  • Promising but early Stellate ganglion blockWeight lossElectroacupuncture
  • Not enough evidence Cooling or avoiding triggers
  • Evidence says no, or unsafe Traditional acupuncture

Each use is rated separately, from the scorecard in this guide. Safety cautions are spelled out in the guide itself. How we grade

On this page
  1. Seven years is the middle of the range, not the end
  2. Hot flashes start in a small cluster of brain cells
  3. Frequent hot flashes travel with higher heart risk
  4. In hot flash trials, dummy treatments work surprisingly well
  5. Hormone therapy still sets the bar
  6. Older drugs and a nerve block found a second job
  7. The hot flash options table
  8. When night sweats may not be menopause
  9. Questions readers ask
  10. The bottom line

Key takeaways

  • In a federally funded study of 1,449 U.S. women with frequent hot flashes, the median length was 7.4 years, and more than half had them for over seven years12.
  • Hot flashes appear to start in a small cluster of brain cells that loses estrogen’s restraint, and that discovery led to a new class of hormone-free drugs345.
  • Women who reported frequent hot flashes at more than a third of study visits had a 77% higher rate of later heart attacks, strokes and similar events than women who reported them less often, a link that doesn’t prove hot flashes cause heart disease6.
  • Across 24 trials, hormone therapy cut weekly hot flashes about 75% more than a placebo did, while acupuncture did no better than a fake version in a 327-woman trial711.
  • In hot flash trials, women on dummy treatments improve by as much as two-thirds, so a remedy that seemed to work may not beat a placebo78.

If your hot flashes started while your periods were still regular or just starting to change, you may be in for a long season. In a large federally funded study, women whose hot flashes began that early had them for a median of more than 11.8 years2.

That finding comes from the Study of Women’s Health Across the Nation, or SWAN2. Among the 1,449 women in the analysis who had frequent hot flashes, the median was 7.4 years1. More than half had them for longer than seven years2.

The researchers wrote that clinical guidelines tend to underestimate how long hot flashes last2. That gap matters if you were told to wait them out, or to treat them only briefly.

Researchers have also traced hot flashes to a few brain cells, linked frequent ones to heart risk, and sorted treatments that work from those that mostly ride the placebo effect. This is what they found.

Seven years is the middle of the range, not the end

SWAN enrolled more than 3,000 women in their 40s and early 50s and checked on them about once a year from 1996 to 201312. For this analysis, published in JAMA Internal Medicine in 2015, the team focused on women who had hot flashes or night sweats on at least 6 of the previous 14 days12. Nancy Avis of Wake Forest University led the work1.

When the first hot flash arrived mattered most. Women whose hot flashes began while their periods were still regular, or early in the transition, had them for a median of more than 11.8 years, including 9.4 years after their last period2. Women whose hot flashes started only after their periods ended had them for a median of 3.4 years2.

Length also differed by group1:

Women in SWAN Median years of frequent hot flashes
African American 10.1
Hispanic 8.9
Non-Hispanic white 6.5
Chinese 5.4
Japanese 4.8

Women with more depressive symptoms, anxiety or stress, and those with less schooling, also had hot flashes longer1. The study can’t say why.

Some women were still having hot flashes when the study ended, so the authors said the true duration may be longer1. NIH agencies funded the work, and one author reported ties to drug companies1.

If yours run long, you have plenty of company, and you aren’t doing something wrong. That’s a good reason to look for options that are safe to use for years, not weeks.

Hot flashes start in a small cluster of brain cells

As recently as 2013, a review by University of Arizona researchers called the cause of hot flashes unknown, though their own lab work held the leads4.

Naomi Rance, a University of Arizona professor of pathology and neurology, spotted the first clue while training at Johns Hopkins University. In brain tissue from women past menopause, a group of nerve cells in the hypothalamus had grown larger35. The team also found that these cells were more active and made more of a signaling chemical called neurokinin B5.

Because the cells also make kisspeptin and dynorphin, scientists call them KNDy neurons4.

Rat studies filled in the chain34:

  • KNDy cells send fibers to brain areas that manage heat loss, and those areas carry a receptor called NK3.
  • Switching on NK3 in one of those areas lowered rats’ body temperature.
  • Destroying KNDy cells reduced the widening of skin blood vessels that sheds heat, and it partly blocked estrogen‘s effect on body temperature.

The working idea is that estrogen normally keeps these cells in check. When estrogen falls, they release more neurokinin B into the brain’s temperature-control areas, which can switch on the body’s heat-release system34. The 2013 review framed this as a hypothesis built mostly on animal data4.

Human tests came next. In a 2015 placebo-controlled study, an IV infusion of neurokinin B gave hot flashes to women who hadn’t reached menopause5. In a 2017 investigator-led trial in The Lancet, researchers tested an experimental pill that blocks NK3. Over four weeks, it cut weekly hot flashes by 45 percentage points more than a placebo, according to the trial’s first author5.

The FDA has since approved fezolinetant, a hormone-free drug that blocks NK38. Our menopause sleep article covers it and a newer drug, elinzanetant, including their label warnings.

Rance credited federal funding for basic research3. For readers who see the body as a self-regulating system, the story fits: a hot flash is a temperature-control circuit reacting to a hormone change.

Frequent hot flashes travel with higher heart risk

In 2021, a SWAN team writing in the Journal of the American Heart Association reported on 3,083 women followed for up to 22 years, with as many as 16 study visits each6. The researchers counted heart attacks, strokes, heart failure and procedures to reopen blocked arteries, fatal or not. There were 231 such events6.

Women with frequent hot flashes at the start, on 6 or more days in two weeks, had a 51% higher rate of these events than women with none6. Occasional hot flashes, on 1 to 5 days, showed no link6.

Persistence mattered more. Women who reported frequent hot flashes at more than a third of their visits had a 77% higher rate than women who reported them less often6. Those figures held after the team accounted for standard heart risk factors, medicines and background6.

The study summary didn’t give event rates for each group, so we can’t turn those percentages into personal odds. Across all the women, 231 of 3,083 had an event, about 7.5% over as long as 22 years, by our math.

This was an observational study, so it shows a link, not a cause. It can’t tell you whether treating hot flashes protects the heart. The authors suggested that frequent hot flashes may be a heart risk factor unique to women6.

Treat that as a nudge, not a scare. If your hot flashes are frequent or long-running, know your blood pressure, cholesterol and blood sugar numbers. Our companion article on menopause covers heart changes after the final period.

In hot flash trials, dummy treatments work surprisingly well

Hot flashes respond strongly to placebo. In a Cochrane review of hormone trials, women on dummy pills saw their hot flashes drop 57.7% from start to finish7. The Menopause Society’s 2023 review of hormone-free treatments said placebo groups in those trials improve by 20% to 66%, and more anxious women respond more8.

Acupuncture shows why that matters. In a trial published in 2016 in the Annals of Internal Medicine, researchers in Australia enrolled 327 women with at least seven moderate hot flashes a day11. Every woman also fit a traditional Chinese medicine pattern called kidney yin deficiency, so the trial respected the tradition’s own way of choosing patients11.

Half got 10 real acupuncture treatments over eight weeks. The other half got a sham version with blunt needles that touch the skin but don’t pierce it1112.

Both groups improved by about 40%, and the gains lasted six months12. But real needling beat the sham by almost nothing: end-of-treatment hot flash scores were 15.36 and 15.0411. No serious side effects were reported, and Australia’s national health research council paid for the study1112.

Lead author Carolyn Ee, a family doctor trained in Chinese medicine, pointed to placebo, the value of talking through symptoms at a clinic, and hot flashes easing over time12. The Menopause Society doesn’t recommend traditional acupuncture for hot flashes8. It called electroacupuncture, acupuncture with a mild electric current, more promising but wants more research first8.

If an herb or treatment eased your hot flashes, that relief was real. The open question is what caused it. Only a comparison with a convincing fake can separate the remedy from time, care and expectation.

Hormone therapy still sets the bar

The Menopause Society’s 2023 statement still ranks hormone therapy as the most effective hot flash treatment8. A Cochrane review, a pooled analysis of trials, measured the size of that edge7.

It combined 24 trials with 3,329 women who took estrogen pills, alone or with a progestogen, or a placebo for three months to three years7. Hormones cut weekly hot flashes 75% more than placebo, about 18 fewer a week7. That works out to roughly 2.6 fewer a day, by our math. Severity fell too7.

Side effects were somewhat more common on hormones, but women on placebo were far more likely to drop out because their treatment wasn’t working7. One caveat: the review dates from 2004, and its trials were short7.

Some women can’t take hormones. The 2023 statement names estrogen-sensitive cancers, heart disease, a past heart attack or stroke, and a history or inherited risk of blood clots8. Others would rather not. Our sibling article on hormone therapy walks through the risks in absolute numbers.

Older drugs and a nerve block found a second job

Several drugs made for other conditions turned out to cool hot flashes. Whether any fits you is a decision to make with your clinician.

Low-dose paroxetine. In 2013, the FDA approved a 7.5 mg bedtime capsule of this antidepressant as the first hormone-free drug for moderate to severe hot flashes89. Its two trials enrolled 1,175 women for 12 or 24 weeks9. Headache, tiredness and nausea were the common side effects9. The label warns it may weaken the breast cancer drug tamoxifen9.

In a pooled analysis of three trials, low-dose estradiol cut 2.3 more hot flashes a day than placebo, and the antidepressant venlafaxine cut 1.8 more8.

Gabapentin. This anti-seizure drug reduced hot flashes at 900 mg a day8. In one trial, a much higher dose matched an estrogen pill for severity, but dizziness, headache and disorientation limited its use8. Dizziness and drowsiness usually fade within about four weeks8.

Oxybutynin. This bladder drug was tested in a Mayo Clinic-led trial of 150 women, first presented at a 2018 cancer meeting and published in 2020 in JNCI Cancer Spectrum1015. About 65% were taking tamoxifen or an aromatase inhibitor, another breast cancer drug1015. Over six weeks, hot flash scores fell about 70% on the lower dose and 86% on the higher one, compared with 27% on placebo, according to the meeting report10. By our math, that’s 43 and 59 percentage points beyond placebo. The published paper called the drug effective and relatively well tolerated15.

Dry mouth, belly pain and harder urination were common side effects1015. The Breast Cancer Research Foundation, a nonprofit, paid for the trial10. The Menopause Society warns that long-term use of drugs in this class may be linked to declines in memory and thinking, especially in older adults8.

Stellate ganglion block. This is an anesthetic injection into a nerve cluster. In one trial of 40 women, measured hot flashes fell 21% after three months with the real shot and not at all with a saltwater sham8. Larger trials are needed8.

Weight loss. Small studies tie weight loss to fewer hot flashes, and the Menopause Society lists it as an option while calling for bigger trials8. It’s the most natural-health-friendly item on this list.

The hot flash options table

This table is our own summary. The numbers come from different trials with different women and lengths, so compare them loosely.

Option Typical effect in trials Evidence Main cautions Source
Hormone therapy About 18 fewer hot flashes a week than placebo (75% more reduction) Strong evidence Not for some health histories; see our sibling article 78
Fezolinetant Fewer hot flashes than placebo through 12 weeks Strong evidence Rare liver enzyme rises; see our menopause sleep article for the FDA warning 8
SSRIs and SNRIs, including low-dose paroxetine 25% to 69% fewer across trials Strong evidence Nausea, headache; paroxetine may weaken tamoxifen 89
Gabapentin Fewer, milder hot flashes Strong evidence Dizziness and drowsiness early on 8
Oxybutynin 70% to 86% lower scores vs. 27% on placebo in a 6-week trial Strong evidence Trials were short; dry mouth; possible memory effects with long use 81015
CBT or clinical hypnosis Recommended; see our menopause sleep article Strong evidence Takes sessions and practice 8
Stellate ganglion block 21% fewer measured hot flashes in one 40-woman trial Promising but early A procedure; few trials 8
Weight loss Fewer hot flashes in small studies Promising but early Needs larger trials 8
Electroacupuncture Beat sham at 8 weeks in a 2021 analysis of 17 studies Promising but early Not yet recommended 8
Traditional acupuncture No better than sham needles Evidence says no, or unsafe Both groups improved about 40% 81112
Cooling or avoiding triggers Little or no trial evidence Not enough evidence Cheap comfort; fine to try 8

Herbal supplements, including black cohosh, aren’t recommended by The Menopause Society8. Our sibling article covers their trials.

Self-care deserves an honest word. One large survey of 4,595 women in China linked drinking to hot flashes, but other studies haven’t found the same pattern8. Our menopause sleep article covers what the small cooling studies showed. A fan and light layers still cost little and may make you more comfortable.

When night sweats may not be menopause

Night sweats can have other causes, too. The Menopause Society lists sleep apnea, an overactive thyroid, acid reflux, diabetes, infections such as tuberculosis and HIV, and some cancers, including lymphoma13. Many medicines can also cause sweating, among them some antidepressants, steroids, thyroid hormone and diabetes drugs13.

Cancer care can cause them, too. Tamoxifen, aromatase inhibitors and treatments that bring on early menopause can all trigger hot flashes and night sweats, and so can hormone treatment or testicle removal for men14.

See a clinician if13:

  • night sweats come with fever, swollen glands or weight loss;
  • sweating started soon after a new medicine (ask whether it could be the cause before changing anything);
  • you have trouble breathing at night, which can point to sleep apnea;
  • you still have regular periods, or sweats come back after they had gone away;
  • sweats begin years after you stopped hormone therapy.

If you take fezolinetant, our menopause sleep article lists the liver warning signs the FDA says to watch for.

Questions readers ask

Will my hot flashes stop if I just wait?

Maybe, but plan for years, not months. In SWAN, hot flashes that began after periods stopped lasted a median of 3.4 years, and early starters had them far longer2.

Do frequent hot flashes damage my heart?

No one has shown that. SWAN found that frequent, persistent hot flashes went along with more heart events, even after accounting for standard risk factors6. That’s a link, not proof of cause, but it’s a fair reason to keep up with your heart checkups.

Can men get hot flashes?

Yes. Certain hormone treatments for cancer, or surgery to remove one or both testicles, can cause hot flashes and night sweats in men14.

The bottom line

Hot flashes often last far longer than women expect, especially when they start early in the transition. They appear to begin with brain cells that react when estrogen falls, and that discovery has produced a new class of hormone-free medicine. Frequent, long-running hot flashes also travel with higher heart risk, which makes them worth taking seriously.

Hormone therapy works best, and several hormone-free prescriptions, CBT and hypnosis have solid evidence too. A nerve block and weight loss look promising, while traditional acupuncture and most self-care tricks haven’t been shown to work in fair tests. Bring your two-week count to a clinician and decide together.

About this article

This article was researched using a Cochrane review, a professional society position statement, published trials, long-term federally funded study data and university reports, all listed below. It was reviewed in October 2026. It is general education, not medical, legal or financial advice.

Sources

  1. Oakes K. “Seven Years of Hot Flashes Common During, After Menopause” (report on Avis NE, et al., JAMA Internal Medicine, published online February 16, 2015, doi:10.1001/jamainternmed.2014.8063). MDedge, February 16, 2015. mdedge.com
  2. The Hospitalist (MDedge). “Vasomotor Symptoms of Menopause Often Persist Longer Than 7 Years” (report on Avis NE, et al., JAMA Internal Medicine, 2015). community.the-hospitalist.org
  3. University of Arizona. “Paving the Way for Promising Treatment for Hot Flashes” (news release on Naomi Rance’s research). ScienceDaily, June 28, 2017. sciencedaily.com
  4. Rance NE, Dacks PA, Mittelman-Smith MA, Romanovsky AA, Krajewski-Hall SJ. “Modulation of Body Temperature and LH Secretion by Hypothalamic KNDy (Kisspeptin, Neurokinin B and Dynorphin) Neurons: A Novel Hypothesis on the Mechanism of Hot Flushes.” Frontiers in Neuroendocrinology, 2013;34(3):211–227 (University of Arizona record). experts.arizona.edu
  5. Prague J. “Neurokinin 3 Receptor Antagonists: The Magic Bullet for Hot Flushes?” The Endocrinologist (Society for Endocrinology), Issue 133, Autumn 2019. doi.org
  6. Thurston RC, Aslanidou Vlachos HE, Derby CA, et al. “Menopausal Vasomotor Symptoms and Risk of Incident Cardiovascular Disease Events in SWAN.” Journal of the American Heart Association, 2021;10(3) (DOAJ record). pubmed.ncbi.nlm.nih.gov
  7. MacLennan AH, Broadbent JL, Lester S, Moore V. “Oral Oestrogen and Combined Oestrogen/Progestogen Therapy Versus Placebo for Hot Flushes.” Cochrane Database of Systematic Reviews, 2004, Issue 4 (CD002978). cochrane.org
  8. Shufelt CL, Brown V, Carpenter JS, et al. “The 2023 Nonhormone Therapy Position Statement of The North American Menopause Society.” Menopause, 2023;30(6):573–590 (copy hosted by the University of Washington). depts.washington.edu
  9. Contemporary OB/GYN. “FDA Approves First Nonhormonal Treatment for Hot Flashes” (Brisdelle, low-dose paroxetine). July 11, 2013. contemporaryobgyn.net
  10. The ASCO Post. “Oxybutynin for Managing Hot Flashes” (report on Leon-Ferre RA, et al., ACCRU SC-1603, San Antonio Breast Cancer Symposium, December 2018). January 25, 2019. ascopost.com
  11. Ee C, et al. “Acupuncture for Menopausal Hot Flashes: A Randomized Trial.” Annals of Internal Medicine, February 3, 2016 (abstract via Read by QxMD, PMID 26784863). pubmed.ncbi.nlm.nih.gov
  12. University of Melbourne. “Real Acupuncture No Better Than Sham Acupuncture for Treating Hot Flushes: Study” (news release). ScienceDaily, January 19, 2016. sciencedaily.com
  13. The Menopause Society. “Night Sweats. What If It’s Not Menopause?” MenoNote, 2025. menopause.org
  14. MedlinePlus. “Cancer Treatment: Dealing With Hot Flashes and Night Sweats.” National Library of Medicine, reviewed September 6, 2024. medlineplus.gov
  15. Leon-Ferre RA, Novotny PJ, Wolfe EG, et al. “Oxybutynin vs Placebo for Hot Flashes in Women With or Without Breast Cancer: A Randomized, Double-Blind Clinical Trial (ACCRU SC-1603).” JNCI Cancer Spectrum, 2020;4(1):pkz088 (Mayo Clinic publication record). mayoclinic.elsevierpure.com